SCOPUS 정보 검색 플랫폼

American Journal of Nephrology

Volumn 45, Issue 1, 2017, Pages 60-62

Complement Activation-Related Pseudo-Allergy: A Fresh Look at Hypersensitivity Reactions to Intravenous Iron

(2) Macdougall, Iain C a Vernon, Katherine a

a KING S COLLEGE HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRIC CARBOXYMALTOSE; IRON; IRON DEXTRAN;

CHRONIC KIDNEY FAILURE; COMPLEMENT ACTIVATION; DRUG CONTROL; ERYTHROPOIESIS; HUMAN; HYPERSENSITIVITY; MINERAL SUPPLEMENTATION; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; DRUG EFFECT; DRUG HYPERSENSITIVITY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; COMPLEMENT ACTIVATION; DRUG HYPERSENSITIVITY; HUMANS; IRON;

EID: 85000968659 PISSN: 02508095 EISSN: 14219670 Source Type: Journal
DOI: 10.1159/000451069 Document Type: Review

Times cited : (45)

References (7)

1
- 0007458310
- Quantitative aspects of iron deficiency in hypochromic anemia (The parenteral administration of iron)
- Heath CW, Strauss MB, Castle WB: Quantitative aspects of iron deficiency in hypochromic anemia: (the parenteral administration of iron). J Clin Invest 1932; 11: 1293-1312
- (1932) J Clin Invest , vol.11 , pp. 1293-1312
- Heath, C.W.¹ Strauss, M.B.² Castle, W.B.³

2
- 0018898174
- Intravenous iron dextran in clinical medicine
- Hamstra RD, Block MH, Schocket AL: Intravenous iron dextran in clinical medicine. JAMA 1980; 243: 1726-1731
- (1980) JAMA , vol.243 , pp. 1726-1731
- Hamstra, R.D.¹ Block, M.H.² Schocket, A.L.³

3
- 0026546897
- Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients
- Fleming LW, Stewart WK, Parratt D: Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients. Nephrol Dial Transplant 1992; 7: 35-39
- (1992) Nephrol Dial Transplant , vol.7 , pp. 35-39
- Fleming, L.W.¹ Stewart, W.K.² Parratt, D.³

4
- 0141725521
- Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): Possible role in hypersensitivity reactions
- Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM: Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Ann Oncol 2003; 14: 1430-1437
- (2003) Ann Oncol , vol.14 , pp. 1430-1437
- Chanan-Khan, A.¹ Szebeni, J.² Savay, S.³ Liebes, L.⁴ Rafique, N.M.⁵ Alving, C.R.⁶ Muggia, F.M.⁷

5
- 85001073675
- Distinct in vitro complement activation by various intravenous iron preparations
- Hempel CJ, Poppelaarsa F, Gaya Costa M, Franssen CF, Vlaam TP, Daha MR, Berger SP, Seelen MA, Gaillard CA: Distinct in vitro complement activation by various intravenous iron preparations. Am J Nephrol 2016; 45: 49-59
- (2016) Am J Nephrol , vol.45 , pp. 49-59
- Hempel, C.J.¹ Poppelaarsa, F.² Gaya Costa, M.³ Franssen, C.F.⁴ Vlaam, T.P.⁵ Daha, M.R.⁶ Berger, S.P.⁷ Seelen, M.A.⁸ Gaillard, C.A.⁹

6
- 84907598811
- Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
- Szebeni J: Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 2014; 61: 163-173
- (2014) Mol Immunol , vol.61 , pp. 163-173
- Szebeni, J.¹

7
- 84945930081
- Hypersensitivity to intravenous iron: Classification, terminology, mechanisms and management
- Szebeni J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Rampton D, Weiss G, Folkersen J: Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol 2015; 172: 5025-5036
- (2015) Br J Pharmacol , vol.172 , pp. 5025-5036
- Szebeni, J.¹ Fishbane, S.² Hedenus, M.³ Howaldt, S.⁴ Locatelli, F.⁵ Patni, S.⁶ Rampton, D.⁷ Weiss, G.⁸ Folkersen, J.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.